Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.
Ponton
C
C
Liver Transplantation Unit, University Hospital of Santiago, Santiago de Compostela, Spain.
Vizcaíno
L
L
Tomé
S
S
Otero
E
E
Molina
E
E
Castroagudín
J F
JF
López-Lago
A
A
Varo Pérez
E
E
D000293:Adolescent; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D007677:Kidney Function Tests; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011517:Prothrombin Time
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009173:Mycophenolic Acid; D001663:Bilirubin